COCCETTI PAOLA

Lambiase, A., Spandri, G., Moukham, H., Toini, E., D’Urzo, A., Zecca, G., et al. (2026). Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. NEUROTHERAPEUTICS, 23(1) [10.1016/j.neurot.2025.e00825]. Dettaglio

Moukham, H., Spandri, G., Lambiase, A., Serio, S., Santoro, V., Piccinelli, A., et al. (2025). Targeting NAFLD via AMPK activation and Lipid droplet clearance: The Role of natural bioactive compounds. Intervento presentato a: SIB "Nutrition and Environment" and "Membrane", Bologna, Italia. Dettaglio

Moukham, H., Galli, F., Spandri, G., Lambiase, A., Serio, S., Santoro, V., et al. (2025). Glabranin as a natural modulator of AMPK signaling and lipid metabolism in non-alcoholic fatty liver disease. Intervento presentato a: Forum Nazionale della Biodiversità 2025, Milano, Italia. Dettaglio

Lambiase, A., Moukham, H., Spandri, G., Solana-Manrique, C., Paricio, N., Tripodi, F., et al. (2025). Neuroprotective effects of verbascoside on eukaryotic models of Parkinson’s disease. Intervento presentato a: PhD day 2025, Padova, Italia. Dettaglio

Spandri, G., Lambiase, A., Moukham, H., Toini, E., Zecca, G., Grassi, F., et al. (2025). Identification of new sustainable biomolecules with neuroprotective effects: a multifaceted screening of the Mediterranean biodiversity. Intervento presentato a: BtBs day 2025, Milano, Italia. Dettaglio